![Lu Yuan Xu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lu Yuan Xu
Financieel Directeur/CFO bij OBIO TECHNOLOGY (SHANGHAI) CORP., LTD.
Oorsprong van het eerstegraads netwerk van Lu Yuan Xu
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 16 | |
Shanghai Genon Biological Product Co., Ltd.
![]() Shanghai Genon Biological Product Co., Ltd. BiotechnologyHealth Technology Shanghai Genon Biological Product Co., Ltd. engages in the research and development, manufacture, and sale of animal-derived protein and biological products. Its products include plasma series, blood cell series, and peptide series. Its business scope includes production of animal-derived feed products such as plasma protein powder, hemoglobin powder, and intestinal membrane protein powder; sale of concentrated feed. The company was founded on July 21, 2005 and is headquartered in Shanghai, China.
10
| Private Company | Biotechnology | 10 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Lu Yuan Xu via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Yangzhou University | College/University | Undergraduate Degree | |
3D MEDICINES INC. | Pharmaceuticals: Major | Director/Board Member | |
Shanghai Vitalgen Biopharma Co., Ltd.
![]() Shanghai Vitalgen Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Vitalgen Biopharma Co., Ltd. is a company based in Shanghai, China that engages in drug research and development services. The Chinese company was founded in 2020. The CEO is Xiao Ping Zhao. | Miscellaneous Commercial Services | Director/Board Member | |
Shanghai University of Finance & Economics
![]() Shanghai University of Finance & Economics Other Consumer ServicesConsumer Services Shanghai University of Finance and Economics engages in the provision of educational services. It offers courses under the following school and departments: business, accountancy, finance, international business administration, economics, public economics and administration, humanities, law, information management and engineering, statistics, foreign languages, mathematics, international cultural exchange, professional and international education and continuing education. The company was founded in 1917 and is headquartered in Shanghai, China. | College/University | Undergraduate Degree | |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
University of California San Diego | College/University | Undergraduate Degree | |
Shenzhen Sinaean Co Tech Energy Technology Co., Ltd.
![]() Shenzhen Sinaean Co Tech Energy Technology Co., Ltd. Electrical ProductsProducer Manufacturing Shenzhen Sinaean Co Tech Energy Technology Co., Ltd. operates a thermal power plant. The private company is based in Shenzhen, China. | Electrical Products | Director/Board Member | |
GUOSEN SECURITIES CO., LTD. | Investment Banks/Brokers | Corporate Officer/Principal | |
Dartmouth Medical School | College/University | Doctorate Degree | |
Shanghai Jiao Tong University | College/University | Doctorate Degree | |
Hrain Biotechnology Co., Ltd.
![]() Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Shanghai Senyu Media Holding Co., Ltd.
![]() Shanghai Senyu Media Holding Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Senyu Media Holding Co., Ltd. engages in the copyright trading and co-operating with radio and television network, media operators, and new media. The company was founded on August 5, 2010 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
Jiangsu University | College/University | Undergraduate Degree | |
Tongji University | College/University | Corporate Officer/Principal | |
Shanghai Transgenic Research Center | Chairman | ||
Shanghai Rui Dong Hospital | Chairman | ||
The University of Edinburgh | College/University | Graduate Degree |
Statistieken
Internationaal
China | 16 |
Verenigde Staten | 3 |
Verenigd Koninkrijk | 2 |
Sectoraal
Consumer Services | 9 |
Health Technology | 5 |
Commercial Services | 3 |
Producer Manufacturing | 2 |
Finance | 2 |
Operationeel
Director/Board Member | 31 |
Corporate Officer/Principal | 7 |
Undergraduate Degree | 5 |
Chairman | 5 |
Independent Dir/Board Member | 5 |
Sterkste connecties
Insiders | |
---|---|
Guo Xiang Cheng | 6 |
Pai Zhu | 6 |
Gang Wang | 4 |
Xiao Gao | 2 |
Ke Jia Yuan | 2 |
Li Ning Gan | 2 |
Yuan Yuan Xu | 2 |
Hong Wei Ren | 2 |
Zhao Rui Song | 1 |
Long Xia | 1 |
Jun Yi Pan | 1 |
Si Jie Song | 1 |
Fu Jie Wang | 1 |
Zheng Qi Song | 1 |
Rui Dong Pan | 1 |
- Beurs
- Insiders
- Lu Yuan Xu
- Bedrijfsconnecties